A detailed history of Baker Bros. Advisors LP transactions in Generation Bio Co. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,944,945 shares of GBIO stock, worth $2.76 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,944,945
Previous 1,206,957 61.14%
Holding current value
$2.76 Million
Previous $3.4 Million 41.17%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.16 - $3.51 $1.59 Million - $2.59 Million
737,988 Added 61.14%
1,944,945 $4.8 Million
Q2 2024

Aug 14, 2024

BUY
$2.64 - $4.35 $2.21 Million - $3.64 Million
835,738 Added 225.13%
1,206,957 $3.4 Million
Q1 2024

May 15, 2024

BUY
$1.73 - $4.07 $642,208 - $1.51 Million
371,219 New
371,219 $1.51 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $83.8M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.